Candel Therapeutics Inc (NASDAQ:CADL) does about 5.45M shares in volume on a normal day but saw 1004541 shares change hands in Friday trading. The company now has a market cap of 264.74M USD. Its current market price is $9.02, marking an increase of 7.00% compared to the previous close of $8.43. The 52 week high reached by this stock is $11.40 whilst the lowest price level in 52 weeks is $0.66.
Candel Therapeutics Inc (CADL) has a 20-day trading average at $6.38 and the current price is -20.88% off the 52-week high compared with 1266.67% distance from its 52-week low. The 50-day simple moving average of the closing price is $3.71 and its 200-day simple moving average is $1.78. If we look at the stock’s price movements over the week, volatility stands at 13.84%, which increases to 20.43% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 78.75 to suggest the stock is overbought.
The consensus objective for the share price is $11.00, suggesting that the stock has a potential upside of 18.0% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on December 02, 2022 when H.C. Wainwright initiated the stock to “Buy” and issued a price target of $11. UBS initiated its price target at $9.
Candel Therapeutics Inc (CADL) stock is up 41.16% over the week and 40.94% over the past month. Its price is 513.61% year-to-date and 467.30% over the past year.
To reach the target analysts have set, the stock logically needs to grow 18.0 percent from here.
The company has a return on investment of -145.35% and return on equity of -125.50%. The beta has a value of -0.93. Price to book ratio is 20.68.
